PTAC Research Grant supports investigators studying CFTR restoration and gene repair or replacement to inform new therapies for people with cystic fibrosis not served by approved modulators.
The Fall 2026 cycle replaces Spring 2026, moving the deadline from May 12 to December 8, 2026, and the earliest start from November 1, 2026, to May 1, 2027. Added rules limit applicants to one research grant and one pilot-and-feasibility application per 12 months, for distinct projects.
PTAC Postdoctoral Research Fellowship Award supports postdoctoral researchers in mentored basic science to advance therapies that restore CFTR function or repair or replace the defective gene.
PTAC Pilot and Feasibility Award supports CF researchers, including new investigators, to test hypotheses, methods, and technologies aimed at restoring CFTR function or repairing the gene to advance a cure.
Path to a Cure Collaborative Research Grant supports research teams developing CFTR gene repair, replacement, and delivery technologies to restore CFTR function and advance new cystic fibrosis therapies.
PTAC Postdoc-to-Faculty Transition Award supports postdoctoral fellows in basic research to repair, replace, or restore CFTR while helping them establish independent cystic fibrosis research careers.
Cystic Fibrosis Foundation’s Research Grants support researchers studying CF disease mechanisms through basic science to deepen understanding of the disease and identify prevention or treatment strategies.